Compounds > meglumine

meglumine and epirubicin

meglumine has been researched along with epirubicin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Anderson, WR; Birch, BR; Cooper, AJ; Harris, NM; Lwaleed, BA; Solomon, LZ1
Cooper, AJ; Harris, NM; Lwaleed, BA; Mackie, SJ; Sharma, DM1
Brunton, T; Evans, A; Henderson, SA; Jordan, LB; Muhammad Gowdh, N; Purdie, CA; Thompson, AM; Vinnicombe, S1
Buckley, DL; Dall, BJ; Dodwell, D; Farrow, IM; Georgiou, L; Hanby, AM; Hughes, TA; Perren, TJ; Sharma, N; Stevens, W; Wilson, DJ; Windel, LM1

Other Studies

5 other study(ies) available for meglumine and epirubicin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma.
    Cancer, 2003, Jan-01, Volume: 97, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Division; Drug Synergism; Epirubicin; Flow Cytometry; gamma-Linolenic Acid; Humans; Meglumine; Microscopy, Confocal; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2003
Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin.
    Prostaglandins, leukotrienes, and essential fatty acids, 2006, Volume: 75, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Eicosapentaenoic Acid; Epirubicin; Fatty Acids, Omega-3; Humans; Meglumine; Mitomycin; Urinary Bladder Neoplasms

2006
Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy.
    The British journal of radiology, 2018, Volume: 91, Issue:1087

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Tumor Burden

2018
Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response.
    The British journal of radiology, 2021, Jul-01, Volume: 94, Issue:1123

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Trastuzumab; Tumor Burden

2021